Purple Biotech to Present Data for its Lead Oncology Drug CM24 at the AACR Special Conference on Advances in Pancreatic Cancer Research
September 10, 2024 07:00 ET
|
Purple Biotech Ltd.
REHOVOT, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that...
TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against Metastatic Cancer
September 10, 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candi-date Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against
TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
September 05, 2024 07:00 ET
|
TransCode Therapeutics, Inc.
TransCode Therapeutics Awarded $2 Million NIH Grant to Support Clinical Evaluation of Lead Candidate
Movember Announces Three Year Partnership With the International Society for Sexual Medicine
September 04, 2024 07:00 ET
|
Movember Canada
Movember is kicking off Prostate Cancer Awareness Month by announcing a new three-year partnership with the International Society for Sexual Medicine.
Three Complete Responses in Azer-Cel Allogeneic CD19 CAR T Phase 1b Trial in Blood Cancer (Diffuse Large B-Cell Lymphoma)
September 03, 2024 08:30 ET
|
Imugene Limited
Three complete responses in azer-cel allogeneic CD19 CAR T Phase 1b trial in blood cancer (Diffuse Large B-Cell Lymphoma)
Claritas NucMed Technologies Secures Approval for its Subsidiary Claritas NucMed Tech Brazil to Forge Ahead the Commercialization of its Cutting-Edge Nuclear Medicine Software Solutions in Brazil
September 02, 2024 10:00 ET
|
Claritas HealthTech Ltd
Claritas NucMed Technologies Secures Approval for its Subsidiary Claritas NucMed Tech Brazil to Forge Ahead the Commercialization of its leading SaMDs
Rakovina Therapeutics Announces 2024 Q2 Financial Results and Provides Corporate Update
August 30, 2024 16:10 ET
|
Rakovina Therapeutics Inc
All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a...
CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 30, 2024 08:00 ET
|
CG Oncology Inc.
CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Immuneering to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
August 29, 2024 08:00 ET
|
Immuneering Corporation
Immuneering to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
ImCheck obtient 20,18 millions d’euros de financement public dans le cadre du plan France 2030
August 29, 2024 05:00 ET
|
ImCheck Therapeutics SAS
ImCheck reçoit un financement non-dilutif significatif afin d’accélérer l’avancement de deux programmes innovants, dans le traitement des cancer et des maladies infectieuses, en ligne avec l’ambition...